A detailed history of Sarissa Capital Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Sarissa Capital Management LP holds 1,110,000 shares of CYTK stock, worth $57.7 Million. This represents 14.58% of its overall portfolio holdings.

Number of Shares
1,110,000
Previous 1,110,000 -0.0%
Holding current value
$57.7 Million
Previous $60.1 Million 2.55%
% of portfolio
14.58%
Previous 10.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $38.8 Million - $60.8 Million
810,000 Added 270.0%
1,110,000 $60.1 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $19.1 Million - $32.4 Million
300,000 New
300,000 $21 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.9B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Sarissa Capital Management LP Portfolio

Follow Sarissa Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Capital Management LP with notifications on news.